Arterial hypertension is a major cause of mortality and morbidity worldwide. Medical therapy is the most common treatment. However, in some cases there is a persistent high blood pressure despite medical therapy. These patients with medication refractory arterial hypertension can be treated by renal denervation. Until now an endovascular approach has been used. There are however limitations in eligibility based on vascular or anatomical anomalies. For these patients, as well as other patients eligible for renal denervation, robot-assisted renal denervation has the potential to become a surgical treatment option based on our findings.
Keyphrases
- arterial hypertension
- robot assisted
- end stage renal disease
- newly diagnosed
- blood pressure
- healthcare
- ejection fraction
- minimally invasive
- chronic kidney disease
- prognostic factors
- peritoneal dialysis
- stem cells
- type diabetes
- cardiovascular disease
- coronary artery disease
- risk assessment
- skeletal muscle
- weight loss
- heart rate
- human health
- adverse drug